AMA CPT® Assistant - 2004 Issue 4 (April)
Anatomic Pathology (April 2004)
April 2004 page 15 Coding Consultation: Questions and Answers Pathology, 87904 (Q&A) Question What is the intended use of code 87904 ? AMA Comment Code 87904 , Infectious agent phenotype analysis by nucleic acid (DNA or RNA) with drug resistance tissue culture analysis, HIV 1; each additional 1 through 5 drugs tested (List separately in addition to code for primary procedure) , is intended to be reported for each additional one through five drugs with one unit of this code. For example, if 15 drugs are tested, then code 87904 should be reported once in addition to code 87903 , Infectious agent...
Subscribe or sign in to view the full article.
Article Overview
This April 2004 Anatomic Pathology Q&A addresses a CPT coding question from pathology and explains how the article frames reporting for a specific laboratory add-on service. It is aimed at coders and pathology billing staff who need to understand the scope of the guidance and the surrounding coding context without reading the full premium discussion.
Why This Topic Matters
The article helps readers determine whether a pathology coding question matches their current work by clarifying the general reporting scenario covered in the Q&A. It is relevant to professionals who handle CPT-based laboratory and pathology coding guidance.
Article Sections
-
April 2004 page 15
Introductory page reference for the Q&A content in this issue. It situates the guidance within the April 2004 pathology coding section.
-
Coding Consultation: Questions and Answers
A question-and-answer format focused on pathology coding guidance. The section presents the topic discussed in the AMA commentary and the related reporting context.
-
Question
The coding question presented by the article. It frames the specific reporting issue addressed in the response.
-
AMA Comment
The editorial response providing general guidance on the reporting scenario. It gives the broader coding context and clarifies the article's intended interpretation of the service.
What You Will Learn
- The general topic addressed by the pathology Q&A
- How the article frames a CPT reporting question
- The kind of laboratory/pathology coding scenario discussed in the AMA commentary
- The scope of the guidance associated with an add-on service in the article
Who Should Read This
- Pathology coders
- Medical billers
- Laboratory billing staff
- Compliance staff
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com